Ferrari, Vittorio Domenico
 Distribuzione geografica
Continente #
NA - Nord America 78
EU - Europa 42
AS - Asia 11
AF - Africa 1
Totale 132
Nazione #
US - Stati Uniti d'America 77
FR - Francia 11
IT - Italia 10
RU - Federazione Russa 4
CN - Cina 3
DE - Germania 3
ES - Italia 3
VN - Vietnam 3
AE - Emirati Arabi Uniti 2
DK - Danimarca 2
FI - Finlandia 2
IE - Irlanda 2
KR - Corea 2
PL - Polonia 2
SE - Svezia 2
CA - Canada 1
IN - India 1
LV - Lettonia 1
ZA - Sudafrica 1
Totale 132
Città #
Ashburn 7
Fairfield 6
Seattle 4
Brescia 3
Cabrils 3
Cambridge 3
Dong Ket 3
Houston 3
Wilmington 3
Buffalo 2
Böblingen 2
Dublin 2
Fall River 2
Helsinki 2
Seongnam-si 2
Shanghai 2
Stockholm 2
Warsaw 2
Woodbridge 2
Ann Arbor 1
Beijing 1
Bengaluru 1
Cagliari 1
Chicago 1
Columbus 1
Dallas 1
Henderson 1
Hojbjerg 1
Livorno 1
Montreal 1
Muizenberg 1
Nuremberg 1
Panorama City 1
Paris 1
Portland 1
Riga 1
Riva 1
Rome 1
Sabbio Chiese 1
Salem 1
San Francisco 1
Totale 77
Nome #
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience., file ddc633e4-0f30-4e2e-e053-3705fe0a4c80 75
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma, file ddc633e4-4ccc-4e2e-e053-3705fe0a4c80 43
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy, file a3966c0b-0d9a-43f4-9303-d2010aed1252 10
Eight‐week interval in flushing and locking port‐a‐cath in cancer patients: A single‐institution experience and systematic review, file 0ec6984f-fe1a-4172-ae86-1a924fc2ba95 7
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial, file ddc633e2-bd62-4e2e-e053-3705fe0a4c80 1
Totale 136
Categoria #
all - tutte 800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 800


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 0 0 0 3
2020/202130 2 4 2 4 1 1 3 2 2 1 2 6
2021/202229 3 2 0 1 2 0 1 3 1 0 12 4
2022/202340 2 0 16 6 1 8 1 1 2 1 1 1
2023/202433 1 0 2 1 3 0 4 5 9 7 1 0
Totale 136